Director, Manufacturing Science & Technology (MSAT)

We are currently recruiting for a Director, Manufacturing Sciences and Technology (MSAT). The purpose of this role is to lead, direct and manage the effective performance of a team of MSAT scientists and engineers to deliver technical projects and tasks within OXB, working directly with stakeholders, clients, and third-party Contract Manufacturing Organisations (CMO's) to ensure delivery is on time and to the required quality.

MSAT enable the introduction of new manufacturing facilities, technology, equipment, and processes to Oxford Biomedica. We contribute to the delivery of customer projects, and to the future growth of the company.,

• Accountable for delivery of multiple technical projects/tasks working directly with customers and third party CMOs to ensure project timelines are met according to internal and/or customer needs.


• Proactively identifies and communicates project risk and issues to senior management, relevant internal stakeholders, and external collaborators.


• Provides technical oversight relating to all OXB's manufacturing sites and third party CMO activities.


• Ensures compliance with OXB's Quality, Safety and Environmental systems and procedures.


• Provides scientific expertise and/or process engineering support as and when necessary, for OXB processes and facilities, including facility design, process scale up and new equipment introduction.


• Maintains awareness of external technology and patent landscape in order to ensure OXB remains at the forefront of the industry.


• Develop external client relationships within Pharma/Biotech industry.
  
  Degree or equivalent experience in a relevant Science (e.g. biological sciences, Biochemical Engineering) with substantial relevant experience in an industrial setting


• Extensive knowledge of bioprocess design, scale-up and commercialisation


• Significant experience of GMP manufacturing and knowledge of OXB processes including quality and regulatory requirements


• Understands the health, safety and environmental aspects of the work carried out.


• Strong background in supporting regulatory submissions.


• Significant industrial experience in the scale-up and industrialisation of GMP manufacturing bioprocesses, technical support & process troubleshooting.


• Recognised SME in technical field of expertise covering areas such as technology transfer, USP and DSP development, optimisation and scale-up, single-use disposable systems, aseptic fill/finish, process validation and GMP manufacturing operations.


• Knowledge of quality management systems, environmental, health and safety aspects of the work and regulatory requirements
  
  Oxford Biomedica is a quality and innovation-led viral vector CDMO (Contract Development and Manufacturing Organization) with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.


Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus, and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

What's in it for you:


• Highly competitive total reward packages


• Wellbeing programmes


• Development opportunities


• Welcoming, friendly, supportive colleagues


• A diverse and inclusive working environment


• Our values are: Deliver Innovation, Be Inspiring and Have Integrity


• State of the art laboratory and manufacturing facilities


We want you to feel inspired every day. We're future-focused and our business is growing rapidly. We succeed together through passion, commitment, and teamwork, and so can you.

Collaborate. Contribute. Change lives.

We offer:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient's cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients' cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise., Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient's cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients' cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

Oxford Biomedica, a FTSE4Good constituent, is headquartered in Oxford, UK. It has locations across Oxfordshire, UK and near Boston, MA, US. Learn more at www.oxb.com, www.oxbsolutions.com, and follow us on LinkedIn, Twitter and YouTube.

Life at Oxford Biomedica

We value everyone's unique contribution, we appreciate everyone's individuality, and every job matters.

Your contributions are recognised and appreciated. Your work-life balance matters. We recognise, develop and use your strengths. It's a place where you are valued as a whole person, as an individual and as part of a team.

No matter who you are, or what you do, your work will make a significant difference.

We go the extra mile, every day, because we truly care. We work together as a team to achieve our life changing therapies. Our talented colleagues help to build other people's futures, so can you. We empower each other to be our best.

We have access to like-minded scientists and engineers, working in the latest technologies.

Our community of experts create new life-saving cures. Shaping the business' future through collaboration. Our people are on a continuous professional development journey aided by a thought-provoking environment. A place for experts to be stretched, and future experts to be nurtured. We inspire creativity and deliver great science, and so can you.

Our supportive culture invites talent, while creating future innovators.

We'll give you a place where you can learn, grow and contribute to the future of cell and gene therapy. We create opportunities and invest in our people, promoting ongoing learning. Our defined career pathways provide opportunities for everyone to achieve their career potential. We make a difference, and so can you.